相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sa1274 Efficacy and Safety of Vedolizumab With Advancing Age in Patients With Ulcerative Colitis: Results From the GEMINI 1 Study
Vijay Yajnik et al.
GASTROENTEROLOGY (2015)
Vedolizumab for Induction and Maintenance of Remission in Ulcerative Colitis: A Cochrane Systematic Review and Meta-analysis
Mahmoud H. Mosli et al.
INFLAMMATORY BOWEL DISEASES (2015)
Effects of Vedolizumab Induction Therapy for Patients With Crohn's Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
Bruce E. Sands et al.
GASTROENTEROLOGY (2014)
Efficacy of continued vedolizumab therapy in patients with Crohn's disease who did not respond to vedolizumab induction therapy at week 6
W. J. Sandborn et al.
JOURNAL OF CROHNS & COLITIS (2014)
Inflammatory Bowel Disease
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome
Orlando Garcia-Bosch et al.
JOURNAL OF CROHNS & COLITIS (2013)
Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: A Korean multicenter retrospective study
Kang-Moon Lee et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Inhibition of Leukocyte Trafficking in Inflammatory Bowel Disease
Fabio Cominelli
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease
P. S. A. de Silva et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population
Christina Ha et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
C. Taxonera et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
Jean Frederic Colombel et al.
GASTROENTEROLOGY (2011)
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects
Matthieu Allez et al.
JOURNAL OF CROHNS & COLITIS (2010)
Long-term outcome after infliximab for refractory ulcerative colitis
Marc Ferrante et al.
JOURNAL OF CROHNS & COLITIS (2008)
Adalimumab induction therapy for Crohn disease previously treated with infliximab - A randomized trial
William J. Sandborn et al.
ANNALS OF INTERNAL MEDICINE (2007)
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
T Bongartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Modified pouchitis disease activity index - A simplified approach to the diagnosis of pouchitis
B Shen et al.
DISEASES OF THE COLON & RECTUM (2003)
分享论文
